Preclinical antitumor activity of S-222611, an oral...

Cancer Science 2014 / 08 Vol. 105; Iss. 8

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2

Tanaka, Hidekazu, Hirata, Michinari, Shinonome, Satomi, Wada, Toru, Iguchi, Motofumi, Dohi, Keiji, Inoue, Makiko, Ishioka, Yukichi, Hojo, Kanji, Yamada, Tomomi, Sugimoto, Tatsuya, Masuno, Koichi, Neza
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
105
Language:
english
Journal:
Cancer Science
DOI:
10.1111/cas.12449
Date:
August, 2014
File:
PDF, 1.58 MB
english, 2014
Conversion to is in progress
Conversion to is failed